JP6367545B2 - ルキソリチニブの重水素化誘導体 - Google Patents

ルキソリチニブの重水素化誘導体 Download PDF

Info

Publication number
JP6367545B2
JP6367545B2 JP2013259713A JP2013259713A JP6367545B2 JP 6367545 B2 JP6367545 B2 JP 6367545B2 JP 2013259713 A JP2013259713 A JP 2013259713A JP 2013259713 A JP2013259713 A JP 2013259713A JP 6367545 B2 JP6367545 B2 JP 6367545B2
Authority
JP
Japan
Prior art keywords
deuterium
hydrogen
compound
compounds
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013259713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015117185A5 (enExample
JP2015117185A (ja
Inventor
シルバーマン アイ.ロバート
シルバーマン アイ.ロバート
エフ.リウ ジュリー
エフ.リウ ジュリー
ジェイ.モーガン アダム
ジェイ.モーガン アダム
パンダ バウミック
パンダ バウミック
エル.ハーベソン スコット
エル.ハーベソン スコット
Original Assignee
コンサート ファーマシューティカルズ インコーポレイテッド
コンサート ファーマシューティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コンサート ファーマシューティカルズ インコーポレイテッド, コンサート ファーマシューティカルズ インコーポレイテッド filed Critical コンサート ファーマシューティカルズ インコーポレイテッド
Priority to JP2013259713A priority Critical patent/JP6367545B2/ja
Publication of JP2015117185A publication Critical patent/JP2015117185A/ja
Publication of JP2015117185A5 publication Critical patent/JP2015117185A5/ja
Application granted granted Critical
Publication of JP6367545B2 publication Critical patent/JP6367545B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2013259713A 2013-12-17 2013-12-17 ルキソリチニブの重水素化誘導体 Active JP6367545B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013259713A JP6367545B2 (ja) 2013-12-17 2013-12-17 ルキソリチニブの重水素化誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013259713A JP6367545B2 (ja) 2013-12-17 2013-12-17 ルキソリチニブの重水素化誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018128417A Division JP6830460B2 (ja) 2018-07-05 2018-07-05 ルキソリチニブの重水素化誘導体

Publications (3)

Publication Number Publication Date
JP2015117185A JP2015117185A (ja) 2015-06-25
JP2015117185A5 JP2015117185A5 (enExample) 2017-02-09
JP6367545B2 true JP6367545B2 (ja) 2018-08-01

Family

ID=53530252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013259713A Active JP6367545B2 (ja) 2013-12-17 2013-12-17 ルキソリチニブの重水素化誘導体

Country Status (1)

Country Link
JP (1) JP6367545B2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018172421A (ja) * 2018-07-05 2018-11-08 コンサート ファーマシューティカルズ インコーポレイテッド ルキソリチニブの重水素化誘導体

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX394605B (es) 2015-06-30 2025-03-24 Eiger Group Int Inc Uso de compuestos de cloroquina y clemizol para el tratamiento de afecciones inflamatorias y cancerosas.
WO2017054739A1 (zh) * 2015-09-29 2017-04-06 康朴生物医药技术(上海)有限公司 一种药物组合物及其应用
KR20250070139A (ko) * 2016-05-04 2025-05-20 썬 파마슈티칼 인더스트리즈 인코포레이티드 중수소화된 jak 저해제를 이용한 탈모 장애의 치료
EP3476850B1 (en) 2016-07-25 2024-12-11 Shenzhen TargetRx, Inc. Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
GB201907871D0 (en) * 2019-06-03 2019-07-17 Small Pharma Ltd Therapeutic compositions
WO2021142395A1 (en) * 2020-01-10 2021-07-15 Consynance Therapeutics, Inc. Therapeutic combinations of drugs and methods of using them
EP3902541B1 (en) * 2020-06-02 2022-09-14 Small Pharma Ltd Therapeutic compositions comprising deuterated or partially deuterated n,n-dimethyltryptamine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1966202E (pt) * 2005-12-13 2012-01-03 Incyte Corp Pirrolo[2,3-b] pirimidinas e pirrolo[2,3-b]piridinas substituídas com heteroarilo como inibidores de janus quinase
MX354212B (es) * 2010-03-10 2018-02-19 Incyte Corp Derivados de piperidin-4-il azetidina como inhibidores de janus cinasa 1 (jak1).

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018172421A (ja) * 2018-07-05 2018-11-08 コンサート ファーマシューティカルズ インコーポレイテッド ルキソリチニブの重水素化誘導体

Also Published As

Publication number Publication date
JP2015117185A (ja) 2015-06-25

Similar Documents

Publication Publication Date Title
US20250025467A1 (en) Deuterated derivatives of ruxolitinib
JP6367545B2 (ja) ルキソリチニブの重水素化誘導体
CN104725380B (zh) 卢索替尼的氘代衍生物
US10357499B2 (en) Substituted triazolobenzodiazepines
KR102433283B1 (ko) 룩소리티닙의 중수소화된 유도체
JP6830460B2 (ja) ルキソリチニブの重水素化誘導体
WO2012129381A1 (en) Deuterated preladenant
HK40060909A (en) Deuterated derivatives of ruxolitinib
HK40060909B (en) Deuterated derivatives of ruxolitinib
HK40013863B (en) Deuterated derivatives of ruxolitinib
HK40013863A (en) Deuterated derivatives of ruxolitinib
BR112014031204B1 (pt) Derivados deuterados de ruxolitinib e composição farmacêutica compreendendo os mesmos

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171023

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180423

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180605

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180705

R150 Certificate of patent or registration of utility model

Ref document number: 6367545

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250